ResearcherAmgenActive in the last 2 years
Md
Known by name at one institution; no external author ID yet. Sources: ClinicalTrials.gov.
Their work
- Papers
- 0
- Trials
- 16
- Grants
- 0
- Labs led
- 0
- Collaborators
- 0
2004: 1 trial · 2005: none · 2006: none · 2007: 2 trials · 2008: none · 2009: 1 trial · 2010: none · 2011: 1 trial · 2012: 1 trial · 2013: none · 2014: none · 2015: 1 trial · 2016: 1 trial · 2017: 1 trial · 2018: 1 trial · 2019: 1 trial · 2020: 1 trial · 2021: 1 trial · 2022: 1 trial · 2023: none · 2024: 1 trial · 2025: 1 trial
Trials 16
- AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors Study director NCT07094113↗
- A Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With H… Study director NCT06360354↗
- A Study of Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101) Study director NCT05094336↗
- Study of AMG 994 Monotherapy and AMG 994 and AMG 404 Combination Therapy in Participants With Advanced Solid Tumors Study director NCT04727554↗
- Study of AMG 199 in Subjects With MUC17-Positive Solid Tumors Including Gastric, Gastroesophageal Junction, Colorectal, and Pancreatic Cancers Study director NCT04117958↗
- Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer Study director NCT03362177↗
- A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (Co… Study director NCT03600883↗
- A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer Study director NCT03343301↗
- Safety and Efficacy Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer Study director NCT02713529↗
- Phase 1b Study of CCX872-B in Patients With Pancreatic Adenocarcinoma Study director NCT02345408↗
- Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas Study director NCT01318642↗
- Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia Study director NCT01444456↗
- QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors Study director NCT00819169↗
- Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary Endpoint Study director NCT00613730↗
- QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer Study director NCT00630552↗
- Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced Cancer Study director NCT00101907↗
Closest collaborators
No collaborators recorded.
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.